xcellbio
Total Raised
$41.02MInvestors Count
10Deal Terms
1Funding, Valuation & Revenue
7 Fundings
xcellbio has raised $41.02M over 7 rounds.
xcellbio's latest funding round was a Series C for $1.4M on December 17, 2024.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
12/17/2024 | Series C | $1.4M | Undisclosed Investors | 1 | ||
4/1/2024 | Corporate Minority | |||||
9/13/2021 | Series B | |||||
2/28/2019 | Incubator/Accelerator | |||||
2/16/2017 | Series A |
Date | 12/17/2024 | 4/1/2024 | 9/13/2021 | 2/28/2019 | 2/16/2017 |
|---|---|---|---|---|---|
Round | Series C | Corporate Minority | Series B | Incubator/Accelerator | Series A |
Amount | $1.4M | ||||
Investors | Undisclosed Investors | ||||
Valuation | |||||
Revenue | |||||
Sources | 1 |
xcellbio Deal Terms
1 Deal Term
xcellbio's deal structure is available for 1 funding round, including their Series A from February 16, 2017.
Round | Series A |
|---|---|
Funding Date | |
Pre-Money Valuation | |
Post-Money Valuation | |
Amount Raised | |
Shares Authorized | |
Issuance Price | |
Dividend Rate | |
Liquidation Preferences | |
Liquidation Price | |
Participation | |
Conversion Price | |
Anti Dilution | |
General Voting | |
Board Voting | |
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series A |
xcellbio Investors
10 Investors
xcellbio has 10 investors. Labcorp invested in xcellbio's Corporate Minority funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
4/1/2024 | 4/1/2024 | 1 Corporate Minority | Corporation | North Carolina | ||
2/16/2017 | 9/13/2021 | 2 Series A, Series B (2021) | Venture Capital | California | ||
9/13/2021 | 9/13/2021 | 1 Series B | Venture Capital | New Jersey | ||
Venture Capital | California | |||||
Asset/Investment Management | New York |
First funding | 4/1/2024 | 2/16/2017 | 9/13/2021 | ||
|---|---|---|---|---|---|
Last Funding | 4/1/2024 | 9/13/2021 | 9/13/2021 | ||
Investor | |||||
Rounds | 1 Corporate Minority | 2 Series A, Series B (2021) | 1 Series B | ||
Board Seats | |||||
Type | Corporation | Venture Capital | Venture Capital | Venture Capital | Asset/Investment Management |
Location | North Carolina | California | New Jersey | California | New York |
Loading...